FindTrial
Sign In

To compare the two drugs that is nalbuphine and buprenorphine while using it in spinal anesthesia for lower limb surgeries.

Intrathecal nalbuphine vs Buprenorphine as an adjuvant to Ropivacaine 0.75% heavy in lower limb orthopedic surgeries: A prospective randomized controlled study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049395
Enrollment
60
Registered
2023-02-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Subarachnoid Block: Spinal Anesthesia will be given to patients going for lower limb orthopedic surgeries for maximum of 2hours Control Intervention1: Subarachnoid block: For patients u

Sponsors

Shubham Jain
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical I-II

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To compare the duration of spinal analgesia following intrathecal buprenorphine vs nalbuphine as an adjuvant to ropivacaine 0.75% heavy in orthopedic lower limb surgeryTimepoint: Intraoperative and postoperative period.—

Secondary

MeasureTime frame
Time of onset and maximum duration of sensory block Time of Onset and duration of motor block Postoperative pain assessmentTimepoint: Intraoperatively and postoperatively for a period of 8 hours—

Countries

India

Contacts

Public ContactKalpana verma

Mahatama gandhi medical college and jaipur

kalpana2007.kv@gmail.com7727886029

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026